Interactions of prion protein with intracellular proteins: So many partners and no consequences?

Cellular and Molecular Neurobiology

Volumn 30, Issue 5, 2010, Pages 653-666

  Nieznanski, Krzysztof ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Neurotoxicity; Prion protein; Protein aggregation; Protein protein interactions; Transmissible spongiform encephalopathies

Indexed keywords

ALDOLASE C; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; CASEIN KINASE II; CELL PROTEIN; CHAPERONE; FERRITIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEAT SHOCK PROTEIN 60; HOMEODOMAIN PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MAHOGUNIN; MELANOMA ANTIGEN; NEUROGLOBIN; NEUROTROPHIN RECEPTOR INTERACTING MAGE HOMOLOG; PRION PROTEIN; PROTEIN 14 3 3; PROTEIN BCL 2; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN A2; SIGNAL PEPTIDE; SYNAPSIN; SYNAPSIN I; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2; TUBULIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CREUTZFELDT JAKOB DISEASE; CYTOSOL; ENDOPLASMIC RETICULUM; HUMAN; MICROTUBULE ASSEMBLY; NONHUMAN; OLIGOMERIZATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; INTRACELLULAR SPACE; PROTEIN BINDING; PROTEIN TRANSPORT; PRPC PROTEINS;

EID: 77956267613     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9491-2     Document Type: Review

References (127)

1. Amos LA, Schlieper D (2005) Microtubules and maps. Adv Protein Chem 71:257-298
2. Atkinson BG, Dean RL, Tomlinson J, Blaker TW (1989) Rapid purification of ferritin from lysates of red blood cells using proteinase-K. Biochem Cell Biol 67:52-57
3. Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361-384
4. Basler K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417-428
5. Bendheim PE, Brown HR, Rudelli RD, Scala LJ, Goller NL, Wen GY, Kascsak RJ, Cashman NR, Bolton DC (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42:149-156
6. Berg D, Holzmann C, Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752-762
7. Bouziane M, Miao F, Ye N, Holmquist G, Chyzak G, O'Connor TR (1998) Repair of DNA alkylation damage. Acta Biochim Pol 45:191-202
8. Bragason BT, Palsdottir A (2005) Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol Cell Neurosci 29:232-244
9. Brown DR (2000) Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala (117) →Val mutation. Biochem J 346:785-791
10. Brown DR, Schmidt B, Kretzschmar HA (1998) Prion protein fragment interacts with PrP-deficient cells. J Neurosci Res 52:260-267
11. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344:1-5
12. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347
13. Cañete-Soler R, Reddy KS, Tolan DR, Zhai J (2005) Aldolases A and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light-neurofilament mRNA. J Neurosci 25:4353-4364
14. Canton DA, Litchfield DW (2006) The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal 18:267-275
15. Capellari S, Zaidi SI, Urig CB, Perry G, Smith MA, Petersen RB (1999) Prion protein glycosylation is sensitive to redox change. J Biol Chem 274:34846-34850
16. Carpenter EM, Goddard JM, Chisaka O, Manley NR, Capecchi MR (1993) Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development 118:1063-1075
17. Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red. J Virol 68:2135-2141
18. Chakrabarti O, Hegde RS (2009) Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell 137:1136-1147
19. Chakrabarti O, Ashok A, Hegde RS (2009) Prion protein biosynthesis and its emerging role in neurodegeneration. Trends Biochem Sci 34:287-295
20. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173-19180
21. Chen J, Gao C, Shi Q, Wang G, Lei Y, Shan B, Zhang B, Dong C, Shi S, Wang X, Tian C, Han J, Dong X (2008a) Casein kinase II interacts with prion protein in vitro and forms complex with native prion protein in vivo. Acta Biochim Biophys Sin (Shanghai) 40:1039-1047
22. Chen JM, Gao C, Shi Q, Shan B, Lei YJ, Dong CF, An R, Wang GR, Zhang BY, Han J, Dong XP (2008b) Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Arch Virol 153:1013-1020
23. Cosseddu GM, Andréoletti O, Maestrale C, Robert B, Ligios C, Piumi F, Agrimi U, Vaiman D (2007) Gene expression profiling on sheep brain reveals differential transcripts in scrapie-affected/not-affected animals. Brain Res 1142:217-222
24. Dandoy-Dron F, Benboudjema L, Guillo F, Jaegly A, Jasmin C, Dormont D, Tovey MG, Dron M (2000) Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain. Brain Res Mol Brain Res 76:173-179
25. Di Fede G, Giaccone G, Limido L, Mangieri M, Suardi S, Puoti G, Morbin M, Mazzoleni G, Ghetti B, Tagliavini F (2007) The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease. J Neuropathol Exp Neurol 66:124-130
26. Dong CF, Shi S, Wang XF, An R, Li P, Chen JM, Wang X, Wang GR, Shan B, Zhang BY, Han J, Dong XP (2008a) The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 470:83-92
27. Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, An R, Li XL, Zhang BY, Han J, Dong XP (2008b) Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Med Microbiol Immunol 197:361-368
28. Dormont D, Delpech B, Delpech A, Courcel MN, Viret J, Markovits P, Court L (1981) Hyperproduction of glial fibrillary acidic protein (GFA) during development of experimental scrapie in mice. C R Seances Acad Sci III 293:53-56
29. Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss S, Winnacker EL (1996) Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol 70:4724-4728
30. Faas H, Jackson WS, Borkowski AW, Wang X, Ma J, Lindquist S, Jasanoff A (2009) Context-dependent perturbation of neural systems in transgenic mice expressing a cytosolic prion protein. Neuroimage. doi:10.1016/j.neuroimage.2009. 10.009
31. Faust M, Montenarh M (2000) Subcellular localization of protein kinase CK2. A key to its function? Cell Tissue Res 301:329-340
32. Ferreira A, Rapoport M (2002) The synapsins: beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59:589-595
33. Fioriti L, Dossena S, Stewart LR, Stewart RS, Harris DA, Forloni G, Chiesa R (2005) Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem 280:11320-11328
34. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P, Darlix JL (2001) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem 276:19301-19309
35. Giorgi A, Di Francesco L, Principe S, Mignogna G, Sennels L, Mancone C, Alonzi T, Sbriccoli M, De Pascalis A, Rappsilber J, Cardone F, Pocchiari M, Maras B, Schininà ME (2009) Proteomic profiling of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 9:3802-3814
36. Giubellino A, Burke TR Jr, Bottaro DP (2008) Grb2 signaling in cell motility and cancer. Expert Opin Ther Targets 12:1021-1033
37. Greenberg DA, Jin K, Khan AA (2008) Neuroglobin: an endogenous neuroprotectant. Curr Opin Pharmacol 8:20-24
38. Grenier C, Bissonnette C, Volkov L, Roucou X (2006) Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. J Neurochem 97:1456-1466
39. Gu Y, Hinnerwisch J, Fredricks R, Kalepu S, Mishra RS, Singh N (2003) Identification of cryptic nuclear localization signals in the prion protein. Neurobiol Dis 12:133-149
40. Hachiya NS, Watanabe K, Sakasegawa Y, Kaneko K (2004a) Microtubules-associated intracellular localization of the NH2-terminal cellular prion protein fragment. Biochem Biophys Res Commun 313:818-823
41. Hachiya NS, Watanabe K, Yamada M, Sakasegawa Y, Kaneko K (2004b) Anterograde and retrograde intracellular trafficking of fluorescent cellular prion protein. Biochem Biophys Res Commun 315:802-807
42. Hajj GN, Lopes MH, Mercadante AF, Veiga SS, da Silveira RB, Santos TG, Ribeiro KC, Juliano MA, Jacchieri SG, Zanata SM, Martins VR (2007) Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci 120:1915-1926
43. Han J, Wang X, Yao H, Gao C, Li F, Zhang B, Jiang H, Dong X (2005) Tau-mediated microtubule formation inhibited by prion protein. Neurosci Bull 21:398-403
44. Han J, Zhang J, Yao H, Wang X, Li F, Chen L, Gao C, Gao J, Nie K, Zhou W, Dong X (2006) Study on interaction between microtubule associated protein tau and prion protein. Sci China C Life Sci 49:473-479
45. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, Borchelt DR, Teplow D, Hood L, Burlingame A, Lycke E, Kobata A, Prusiner SB (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274:1-13
46. He L, Eldridge AG, Jackson PK, Gunn TM, Barsh GS (2003a) Accessory proteins for melanocortin signaling: attractin and mahogunin. Ann N Y Acad Sci 994:288-298
47. He L, Lu XY, Jolly AF, Eldridge AG, Watson SJ, Jackson PK, Barsh GS, Gunn TM (2003b) Spongiform degeneration in mahoganoid mutant mice. Science 299:710-712
48. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834
49. Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822-826
50. Heske J, Heller U, Winklhofer KF, Tatzelt J (2004) The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem 279:5435-5443
51. Hornshaw MP, McDermott JR, Candy JM (1995) Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun 207:621-629
52. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924-930
53. Jackson GS, Murray I, Hosszu LL, Gibbs N, Waltho JP, Clarke AR, Collinge J (2001) Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98:8531-8535
54. Jiménez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B, Prelli F (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153:1561-1572
55. Jin JK, Choi JK, Lee HG, Kim YS, Carp RI, Choi EK (1999) Increased expression of CaM kinase II alpha in the brains of scrapie-infected mice. Neurosci Lett 273:37-40
56. 2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J Biol Chem 279:32018-32027
57. Keshet GI, Bar-Peled O, Yaffe D, Nudel U, Gabizon R (2000) The cellular prion protein colocalizes with the dystroglycan complex in the brain. J Neurochem 75:1889-1897
58. Kim SJ, Hegde RS (2002) Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel. Mol Biol Cell 13:3775-3786
59. Kim SJ, Rahbar R, Hegde RS (2001) Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J Biol Chem 276:26132-26140
60. Kim BH, Jun. YC, Jin JK, Kim JI, Kim NH, Leibold EA, Connor JR, Choi EK, Carp RI, Kim YS (2007) Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapieinfected mice. Neurosci Lett 422:158-163
61. Koorts AM, Viljoen M (2007) Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 113:30-54
62. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menéndez-Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ (2007) Diseaseassociated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26:175-188
63. Kurschner C, Morgan JI (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res Mol Brain Res 30:165-168
64. Lechauve C, Rezaei H, Celier C, Kiger L, Corral-Debrinski M, Noinville S, Chauvierre C, Hamdane D, Pato C, Marden MC (2009) Neuroglobin and prion cellular localization: investigation of a potential interaction. J Mol Biol 388:968-977
65. Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801-814
66. Lopez CD, Yost CS, Prusiner SB, Myers RM, Lingappa VR (1990) Unusual topogenic sequence directs prion protein biogenesis. Science 248:226-229
67. Lysek DA, Wüthrich K (2004) Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy. Biochemistry 43:10393-10399
68. Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98:14955-14960
69. Ma J, Wollmann R, Lindquist S (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785
70. Mackenzie A (1983) Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie. J Comp Pathol 93:251-259
71. Mangé A, Crozet C, Lehmann S, Béranger F (2004) Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. J Cell Sci 117:2411-2416
72. Martins VR, Graner E, Garcia-Abreu J, de Souza SJ, Mercadante AF, Veiga SS, Zanata SM, Neto VM, Brentani RR (1997) Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 3:1376-1382
73. McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62
74. Meggio F, Negro A, Sarno S, Ruzzene M, Bertoli A, Sorgato MC, Pinna LA (2000) Bovine prion protein as a modulator of protein kinase CK2. Biochem J 352:191-196
75. Mei GY, Li Y, Wang GR, Zhang BY, Tian C, Chen C, Zhou RM, Wang X, Li XL, Wang KX, Han J, Dong XP (2009) Molecular interaction between PrP protein and the signal protein 14-3-3 beta. Bing Du Xue Bao 25:208-212
76. Messing A, Brenner M (2003) GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43:87-90
77. Miesbauer M, Rambold AS, Winklhofer KF, Tatzelt J (2009) Targeting of the prion protein to the cytosol: mechanisms and consequences. Curr Issues Mol Biol 12:109-118
78. Mironov A Jr, Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ (2003) Cytosolic prion protein in neurons. J Neurosci 23:7183-7193
79. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24:11280-11290
80. Motohashi H, Yamamoto M (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557
81. Myer DL, Bahassi el M, Stambrook PJ (2005) The Plk3-Cdc25 circuit. Oncogene 24:299-305
82. Nandi PK (1997) Interaction of prion peptide HuPrP106-126 with nucleic acid. Arch Virol 142:2537-2545
83. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272:6324-6331
84. Negro A, Meggio F, Bertoli A, Battistutta R, Sorgato MC, Pinna LA (2000) Susceptibility of the prion protein to enzymic phosphorylation. Biochem Biophys Res Commun 271:337-341
85. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284:13291-13295
86. Nieznanski K, Nieznanska H, Skowronek KJ, Osiecka KM, Stepkowski D (2005) Direct interaction between prion protein and tubulin. Biochem Biophys Res Commun 334:403-411
87. Nieznanski K, Podlubnaya ZA, Nieznanska H (2006) Prion protein inhibits microtubule assembly by inducing tubulin oligomerization. Biochem Biophys Res Commun 349:391-399
88. Nogales E (2000) Structural insights into microtubule function. Annu Rev Biochem 69:277-302
89. Oesch B, Teplow DB, Stahl N, Serban D, Hood LE, Prusiner SB (1990) Identification of cellular proteins binding to the scrapie prion protein. Biochemistry 29:5848-5855
90. Osiecka KM, Nieznanska H, Skowronek KJ, Karolczak J, Schneider G, Nieznanski K (2009) Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly. Proteins 77:279-296
91. Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS (2002) Cellsurface prion protein interacts with glycosaminoglycans. Biochem J 368:81-90
92. Pinna LA (2002) Protein kinase CK2: a challenge to canons. J Cell Sci 115:3873-3878
93. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383
94. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38:127-134
95. Rambold AS, Miesbauer M, Rapaport D, Bartke T, Baier M, Winklhofer KF, Tatzelt J (2006) Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell 17:3356-3368
96. Rane NS, Yonkovich JL, Hegde RS (2004) Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J 23:4550-4559
97. Richard M, Biacabe AG, Streichenberger N, Ironside JW, Mohr M, Kopp N, Perret-Liaudet A (2003) Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol 105:296-302
98. Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231). FEBS Lett 413:282-288
99. Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC (2003) Cytosolic prion protein is not toxic and protects against Baxmediated cell death in human primary neurons. J Biol Chem 278:40877-40881
100. Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA (2000) NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27:279-288
101. Salehi AH, Xanthoudakis S, Barker PA (2002) NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem 277:48043-48050
102. Satoh J, Onoue H, Arima K, Yamamura T (2005) The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein. J Neuropathol Exp Neurol 64:858-868
103. Satoh J, Obayashi S, Misawa T, Sumiyoshi K, Oosumi K, Tabunoki H (2009) Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 35:16-35
104. Schmitt-Ulms G, Hansen K, Liu J, Cowdrey C, Yang J, DeArmond SJ, Cohen FE, Prusiner SB, Baldwin MA (2004) Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol 22:724-731
105. Shpetner HS, Vallee RB (1989) Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules. Cell 59:421-432
106. Sisó S, Puig B, Varea R, Vidal E, Acín C, Prinz M, Montrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I (2002) Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol 103:615-626
107. Soane L, Fiskum G (2005) Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins. J Bioenerg Biomembr 37:179-190
108. Spielhaupter C, Schätzl HM (2001) PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 276:44604-44612
109. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229-240
110. Stahl N, Borchelt DR, Prusiner SB (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol- specific phospholipase C. Biochemistry 29:5405-5412
111. Strom A, Diecke S, Hunsmann G, Stuke AW (2006) Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry. Proteomics 6:26-34
112. Sun G, Guo M, Shen A, Mei F, Peng X, Gong R, Guo D, Wu J, Tien P, Xiao G (2005) Bovine PrPC directly interacts with alphaB-crystalline. FEBS Lett 579:5419-5424
113. Szegezdi E, Macdonald DC, Ní Chonghaile T, Gupta S, Samali A (2009) Bcl-2 family on guard at the ER. Am J Physiol Cell Physiol 296: C941-C953
114. Tatzelt J, Maeda N, Pekny M, Yang SL, Betsholtz C, Eliasson C, Cayetano J, Camerino AP, DeArmond SJ, Prusiner SB (1996) Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein. Neurology 47:449-453
115. Thompson RJ, Kynoch PA, Willson VJ (1982) Cellular localization of aldolase C subunits in human brain. Brain Res 232:489-493
116. Turk E, Teplow DB, Hood LE, Prusiner SB (1988) Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 176:21-30
117. Vana K, Zuber C, Nikles D, Weiss S (2007) Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol 27:107-128
118. Wang XF, Dong CF, Zhang J, Wan YZ, Li F, Huang YX, Han L, Shan B, Gao C, Han J, Dong XP (2008) Human tau protein forms complex with PrP and some GSS-and fCJD-related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem 310:49-55
119. Wang X, Bowers SL, Wang F, Pu XA, Nelson RJ, Ma J (2009) Cytoplasmic prion protein induces forebrain neurotoxicity. Biochim Biophys Acta 1792:555-563
120. Warner RG, Hundt C, Weiss S, Turnbull JE (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277:18421-18430
121. Weighardt F, Biamonti G, Riva S (1996) The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays 18:747-756
122. Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, Famulok M, Winnacker EL (1997) RNA aptamers specifically interact with the prion protein PrP. J Virol 71:8790-8797
123. Wong WW, Puthalakath H (2008) Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life 60:390-397
124. Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 20:5383-5391
125. Yehiely F, Bamborough P, Da Costa M, Perry BJ, Thinakaran G, Cohen FE, Carlson GA, Prusiner SB (1997) Identification of candidate proteins binding to prion protein. Neurobiol Dis 3:339-355
126. Yost CS, Lopez CD, Prusiner SB, Myers RM, Lingappa VR (1990) Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343:669-672
127. Zanusso G, Petersen RB, Jin T, Jing Y, Kanoush R, Ferrari S, Gambetti P, Singh N (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274:23396-23404